ガイドラインから実践へ:非常に高い心血管リスクの患者におけるLDL-Cの達成 - EDHIPO MARCAレジスタの分析
Brayan Daniel Cordoba-Melo1,2, Sebastián Seni-Molina1, Juan Pablo Arango-Ibanez1,2
1Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Lipids in health and disease
|September 2, 2025
まとめ
低密度脂質コレステロール (LDL- C) の目標達成は,脂質低下療法にもかかわらず,高リスク患者では最適以下である. 冠動脈疾患の患者の脂質コントロールの改善には,頻繁なフォローアップと併用療法が不可欠です.
科学分野:
- 心臓病科
- 公衆衛生
背景:
- 心血管疾患は世界の主要な死因であり,脂質不全症はその進行に大きく寄与する.
- 脂質低下療法 (LLT) の進歩にもかかわらず,低密度脂質タンパク質コレステロール (LDL- C) の目標値を達成することは,多くの患者にとって課題です.
研究 の 目的:
- 冠動脈疾患 (CAD) に起因する非常に高い心血管リスク (CVR) を有するコロンビアの患者におけるLDL-C目標の達成度を評価する.
- ESC/EASのガイドラインの更新に合わせて目標達成を評価する.
主な方法:
- コロンビアの11の病院で1788人のCAD患者を対象とした多センター研究 (EDHIPO MARCA).
- LDL-C目標の達成は,ESC/EASガイドラインの更新に対応する3つの期間 (2011-2012,2016-2017,2021-2022) にわたって分析されました.
- データには,冠動脈血管図の報告と医療記録が含まれ,LDL-Cの目標値は<70 mg/ dLと<55 mg/ dLであった.
主要な成果:
- フォローアップ時の総LDL- C目標値の達成率は36. 6%でした.
- 目標達成率は指針期間によって異なる.12.1% (2011),42.3% (2016),36.2% (2019).
- フォローアップの頻度増加は,目標達成率の上昇と相関する (32. 9% 1回のフォローアップと 44. 0% 4回のフォローアップ).
結論:
- 非常に高いCVR患者のLLTの広範な使用にもかかわらず,LDL- Cの目標値の達成は不十分である.
- 脂質コントロールの強化は,より頻繁な患者追跡とスタチン以外の組み合わせ治療のより広範な使用を必要とするかもしれません.
さらに関連する動画
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.4K
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
13.5K
関連する概念動画
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
291
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:30Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865